NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/30/2025
Back to search
Official data from USPTO
UZOYA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
05/31/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
01/08/2021
Registration date
11/09/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/09/2021
Last transaction
05/31/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
RUSKIN, MATTHEW
Law office
L60
Current location
TMEG LAW OFFICE 106
Holders and representatives
Holders
Glaxo Group Limited
Representatives
Legal Brand Protection, GSK
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations [ and substances ] for the* prevention and * treatment of [ damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, ] oncological, [ hepatological, ophthalmic, ] respiratory [, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related ] diseases and disorders; vaccines
Publications
History of USPTO decisions and trademark events.
24 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/30/2023
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
12/13/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/22/2022
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
03/23/2022
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
03/22/2022
PLGL
ASSIGNED TO PARALEGAL
03/22/2022
GPNX
NOTIFICATION PROCESSED BY IB
03/12/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
03/12/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/23/2022
FIMP
FINAL DISPOSITION PROCESSED
02/22/2022
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
12/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
11/09/2021
PUBO
PUBLISHED FOR OPPOSITION
08/24/2021
GPNX
NOTIFICATION PROCESSED BY IB
08/22/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/04/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/04/2021
NPUB
NOTICE OF PUBLICATION
08/04/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/22/2021
DOCK
ASSIGNED TO EXAMINER
07/19/2021
MAFR
APPLICATION FILING RECEIPT MAILED
03/23/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/18/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
03/17/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/11/2021
Continuous trademark protection
Get notified about every new filing that threatens UZOYA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.